Pharmaceuticals

The Cannabist Company Holdings Inc.

The Cannabist Company Holdings Inc. released FY2025 9 Months Earnings on November 10 After-Market EST, actual revenue USD 253.7 M, actual EPS USD -0.2573

The Cannabist Company Holdings Inc. released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 79.91 M (forecast USD 86.5 M), actual EPS USD -0.0285

The Cannabist Company Holdings Inc. to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast Revenue USD 86.5 M

The Cannabist Company Holdings Inc. released FY2025 Semi-Annual Earnings on August 7 Pre-Market EST, with actual revenue of USD 173.79 M and EPS of USD -0.2298

The Cannabist Company Holdings Inc. released FY2025 Q2 earnings on August 7 Pre-Market (EST), actual revenue USD 86.35 M (forecast USD 80.1 M), actual EPS USD -0.1606

The Cannabist Company Holdings Inc. to Release FY2025 Q2 Earnings on August 7, Pre-Market EST, Forecast Revenue USD 80.1 M

The Cannabist Company Holdings Inc. released FY2025 Q1 earnings on May 8 Pre-Market EST, actual revenue USD 87.44 M (forecast USD 88.78 M), actual EPS USD -0.068

The Cannabist Company Holdings Inc. to release earnings report on May 8, 2025 Pre-Market EST, forecast revenue USD 88.78 M

The Cannabist Company Holdings Inc. released FY2024 Q4 earnings on March 17 Pre-Market (EST), actual revenue 96.14 M USD (forecast 110.38 M USD), actual EPS -0.1154 USD

The Cannabist Company Holdings Inc. released FY2024 annual earnings on March 17 Pre-Market (EST), actual revenue 458.72 M USD (forecast 472.97 M USD), actual EPS -0.2289 USD

The Cannabist Company Holdings Inc. to Release FY2024 Q4 Earnings on March 13, 2025 Pre-Market EST, Forecast Revenue 110.38 M USD

The Cannabist Company Holdings Inc. released FY2024 Q3 earnings on November 7, Pre-Market EST, with actual revenue of 114.783M (forecast 121.94M) and actual EPS of -0.0039

The Cannabist Company Holdings Inc. released FY2024 9 Months Earnings on November 7 Pre-Market (EST), with actual revenue of 362.584M USD and EPS of -0.1137

The Cannabist Company Holdings Inc. to Release FY2024 Q3 Earnings on November 7, Pre-Market EST; Forecasted Revenue 121.94 M USD

Canaccord Genuity Reaffirms Buy Rating for The Cannabist Company Holdings Inc.

The Cannabist Company Acquires Lakeland Cultivation Facility

The Cannabist Company Holdings expands partnership with Old Pal

OPTIMI HEALTH CORP

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

HCW Biologics

GCL Global

Silexion Therapeutics

BiomX

Micware

MetaVia

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

TCNNF

CRLBF

CBSTF

CURLF

TLRY

GTBIF

IMCC

MSOS

New cannabis regulations are creating disparities between medical-only operators and multistate companies. Medical operators like True Leaf may benefit from improved margins and cash flow, while multistate firms face new tax challenges that could impact earnings. This federal shift in cannabis tax policy is reshaping the industry landscape, influencing valuations and financial performance for various players.

nasdaq

Trulieve Cannabis Corp.

Cresco Labs Inc.

Curaleaf Holdings, Inc.

Tilray Brands

Green Thumb Industries Inc.

IM Cannabis

AdvisorShares Pure US Cannabis ETF

Amplify Alternative Harvest ETF

NVIDIA

Intel

S&P 500

Nasdaq

NVIDIA Corporation

New Cannabis Rules Just Created Winners and Losers: What the Split Schedule Means for Medical Operators and MSOs

CBIH

CBSTQ

Cannabist Company President Resigns, Moves to Consulting Role

Tip Ranks

Cannabis Bioscience International Holdings, Inc.

CANNABIST CO HOLDINGS INC.

Cannabist Company President Resigns, Moves to Consulting Role

Cannabist Company Delays 10-K Amid Restructuring Turmoil

Cannabist Company Delays 10-K Amid Restructuring Turmoil

Cannabist has initiated a court-supervised restructuring, announcing the sale of its Delaware and Ohio operations for a total of $63.5 million. Parma Holdco will acquire Delaware assets for $16.5 million, while Holistic Industries will purchase Ohio subsidiaries for $47 million. Additionally, Cannabist secured a Support Agreement with noteholders representing 60% of its secured notes to support the restructuring process, pending necessary approvals.

TradingView

Cannabist Launches CCAA Restructuring, Sells Delaware and Ohio Assets for $63.5 Million

Cannabist Company Seeks Court Protection as It Sells Key U.S. Cannabis Assets

Cannabist Company Seeks Court Protection as It Sells Key U.S. Cannabis Assets

The Cannabist Company Announces Strategic Transactions and Initiates Proceedings Under the CCAA | CBSTF Stock News

StockTitan

The Cannabist Company Announces Strategic Transactions and Initiates Proceedings Under the CCAA | CBSTF Stock News

Cannabist Company Gains Short-Term Forbearance Extension From Noteholders

Cannabist Company Gains Short-Term Forbearance Extension From Noteholders

The Cannabist Company Holdings Inc.(CBSTF.US)

New Cannabis Rules Just Created Winners and Losers: What the Split Schedule Means for Medical Operators and MSOs

Cannabist Company President Resigns, Moves to Consulting Role

Cannabist Company Delays 10-K Amid Restructuring Turmoil

Cannabist Launches CCAA Restructuring, Sells Delaware and Ohio Assets for $63.5 Million

Cannabist Company Seeks Court Protection as It Sells Key U.S. Cannabis Assets

The Cannabist Company Announces Strategic Transactions and Initiates Proceedings Under the CCAA | CBSTF Stock News

Cannabist Company Gains Short-Term Forbearance Extension From Noteholders